Rana McKay

Rana McKay

UNVERIFIED PROFILE

Are you Rana McKay?   Register this Author

Register author
Rana McKay

Rana McKay

Publications by authors named "Rana McKay"

Are you Rana McKay?   Register this Author

69Publications

1596Reads

26Profile Views

Response of Primary Renal Cell Carcinoma to Systemic Therapy.

Eur Urol 2019 Oct 5. Epub 2019 Oct 5.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Moores Cancer Center, University of California San Diego, San Diego, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.08.035DOI Listing
October 2019

Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer.

Eur Urol Oncol 2019 Sep 19;2(5):584-588. Epub 2018 Oct 19.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.09.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697241PMC
September 2019

Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma.

Eur Urol Oncol 2019 Sep 24. Epub 2019 Sep 24.

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.09.001DOI Listing
September 2019

Clinical implications of genetic aberrations in metastatic prostate cancer.

Curr Opin Urol 2019 Jul;29(4):319-325

Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000647DOI Listing
July 2019

The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2019 Jul 19. Epub 2019 Jul 19.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.07.004DOI Listing
July 2019

Systemic Treatment of Bone Disease in Metastatic Urinary Malignancies.

Eur Urol Focus 2019 Jun 26. Epub 2019 Jun 26.

San Diego, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.06.007DOI Listing
June 2019

Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys 2019 04 11;103(5):1068-1076. Epub 2018 Dec 11.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, San Diego, California; Clinical and Translational Research Institute, University of California San Diego, San Diego, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.12.001DOI Listing
April 2019

Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma.

Clin Genitourin Cancer 2018 10 25;16(5):341-348. Epub 2018 Apr 25.

Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175670PMC
October 2018

Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma.

J Clin Oncol 2018 Oct 29:JCO2018790253. Epub 2018 Oct 29.

Rana R. McKay, Moores Cancer Center, University of California San Diego, San Diego, CA; Dominick Bossé and Toni K. Choueiri, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Dominick Bossé, The Ottawa Hospital Cancer Center, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.0253
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.0253DOI Listing
October 2018

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database.

J Glob Oncol 2018 09;4:1-14

Andre P. Fay, Hospital São Lucas/Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; Rana R. McKay, University of California San Diego, San Diego, CA; Xun Lin and Ronit Simantov, Pfizer Oncology, New York, NY; and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.17.00119
Publisher Site
http://dx.doi.org/10.1200/JGO.17.00119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223429PMC
September 2018

Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.

Int J Radiat Oncol Biol Phys 2018 08 17;101(5):1188-1193. Epub 2018 Apr 17.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Translational Radiation Medicine and Imaging, University of California San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.04.023DOI Listing
August 2018

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.

Clin Genitourin Cancer 2018 04 6;16(2):e327-e333. Epub 2017 Dec 6.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.11.005DOI Listing
April 2018

Neoadjuvant therapy for localized and locally advanced renal cell carcinoma.

Urol Oncol 2018 01 10;36(1):31-37. Epub 2017 Aug 10.

Department of Urology, Moores UCSD Cancer Center, University of California San Diego School of Medicine, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.07.015DOI Listing
January 2018

Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.

Clin Genitourin Cancer 2017 12 21;15(6):652-660.e1. Epub 2017 Mar 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.03.004DOI Listing
December 2017

Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2017 12 31;15(6):724-732. Epub 2017 May 31.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.05.019DOI Listing
December 2017

Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer.

Clin Genitourin Cancer 2017 08 27;15(4):463-471. Epub 2016 Oct 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.10.006DOI Listing
August 2017

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database.

Clin Genitourin Cancer 2017 Aug 12. Epub 2017 Aug 12.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.021DOI Listing
August 2017

Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2017 04 29;15(2):221-229. Epub 2016 Jun 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.06.017DOI Listing
April 2017

Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy.

Clin Genitourin Cancer 2017 04 20;15(2):e289-e298. Epub 2016 Aug 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.08.015DOI Listing
April 2017

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065111PMC
October 2016

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.

Clin Genitourin Cancer 2016 08 17;14(4):e299-305. Epub 2015 Dec 17.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.008DOI Listing
August 2016

CHALLENGE Trial 1 Year Feasibility Results-Letter.

Cancer Epidemiol Biomarkers Prev 2016 08 14;25(8):1277. Epub 2016 Jul 14.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-16-0393DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970942PMC
August 2016

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.

J Clin Oncol 2016 06 4;34(16):1913-20. Epub 2016 Apr 4.

Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321094PMC
June 2016

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma.

J Immunother Cancer 2016 19;4:26. Epub 2016 Apr 19.

Department of Medical Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0129-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837591PMC
April 2016

Statins and survival outcomes in patients with metastatic renal cell carcinoma.

Eur J Cancer 2016 Jan 11;52:155-62. Epub 2015 Dec 11.

Department of Medical Oncology, Tom Baker Cancer Center, 1331 29 Street Northwest, Calgary, AB T2N 4N2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.10.008DOI Listing
January 2016

Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective.

Surg Pathol Clin 2015 Dec;8(4):657-62

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue (DANA 1230), Boston, MA 02215, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2015.08.001DOI Listing
December 2015

The role of miRNAs in prostate cancer.

Eur Urol 2015 Oct 7;68(4):589-90. Epub 2015 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.12.037DOI Listing
October 2015

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma.

Cancer 2015 Oct 8;121(19):3435-43. Epub 2015 Jun 8.

Kidney Cancer Center, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29503DOI Listing
October 2015

Treatment With Galeterone in an Elderly Man With Castration-Resistant Prostate Cancer: A Case Report.

Clin Genitourin Cancer 2015 Aug 31;13(4):e325-e328. Epub 2014 Dec 31.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.12.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563804PMC
August 2015

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Eur Urol 2015 May 7;67(5):952-8. Epub 2015 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.12.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570832PMC
May 2015

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.

J Immunother Cancer 2015 17;3. Epub 2015 Feb 17.

Dana-Farber Cancer Institute, 450 Brookline Avenue (DANA 1230), Boston, MA 02215 USA ; Brigham and Women's Hospital, 75 Francis Street (Thorn Building 504A), Boston, MA 02215 USA ; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0047-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357210PMC
March 2015

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients.

Urology 2015 Feb;85(2):343-9

Division of Urologic Oncology and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295140120
Publisher Site
http://dx.doi.org/10.1016/j.urology.2014.09.053DOI Listing
February 2015

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

Cancer 2015 Jan 18;121(2):311-9. Epub 2014 Sep 18.

Brigham and Women's Hospital, Division of Endocrinology, Diabetes and Hypertension, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28972DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293233PMC
January 2015

The burden of skeletal-related events in patients with prostate cancer and bone metastasis.

Urol Oncol 2015 Jan 30;33(1):17.e9-17.e18. Epub 2014 Oct 30.

Division of Urologic Surgery and Center for Surgery and Public Health, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.09.010DOI Listing
January 2015

Adrenocortical carcinoma: the management of metastatic disease.

Crit Rev Oncol Hematol 2014 Nov 4;92(2):123-32. Epub 2014 Jun 4.

Dana-Farber Cancer Institute, Boston, MA, United States; Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2014.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578298PMC
November 2014

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

Cancer 2015 Jan 18;121(2):311-9. Epub 2014 Sep 18.

Brigham and Women's Hospital, Division of Endocrinology, Diabetes and Hypertension, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28972DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293233PMC
January 2015

Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC).

BJU Int 2014 May 14;113(5b):E67-74. Epub 2014 Feb 14.

Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117702PMC
May 2014

Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer.

Hematol Oncol Clin North Am 2013 Dec 20;27(6):1261-83, ix. Epub 2013 Sep 20.

Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127574PMC
December 2013

Rationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancer.

Drugs 2013 Sep;73(13):1417-30

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-013-0107-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127573PMC
September 2013

Prostate cancer 2012: where do we stand and where are we heading?

Oncology (Williston Park) 2012 Dec;26(12):1222, 1224

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
December 2012